Bill
Bill > HB425
DE HB425
DE HB425An Act To Amend Title 18 Of The Delaware Code Relating To Permitted Disclosures Related To Prescription Drugs.
summary
Introduced
05/30/2018
05/30/2018
In Committee
06/26/2018
06/26/2018
Crossed Over
06/26/2018
06/26/2018
Passed
06/28/2018
06/28/2018
Dead
Signed/Enacted/Adopted
08/28/2018
08/28/2018
Introduced Session
149th General Assembly
Bill Summary
This Act establishes that a contract between a pharmacy benefits manager and a pharmacy may not prohibit a pharmacy or pharmacist from doing any of the following:
AI Summary
This bill establishes that a contract between a pharmacy benefits manager (PBM) and a pharmacy cannot prohibit the pharmacy or pharmacist from: 1) providing an insured patient with information about the retail price of a prescription drug or the amount of the patient's cost share; 2) discussing this price and cost share information with the patient; and 3) selling the patient a more affordable substitute drug, if one is available. The bill applies to PBM-pharmacy contracts entered into, renewed, or extended on or after the effective date of the Act.
Committee Categories
Business and Industry
Sponsors (15)
Andria Bennett (D)*,
Paul Baumbach (D),
David Bentz (D),
Debra Heffernan (D),
Margaret Henry (D),
Helene Keeley (D),
John Kowalko (D),
Sean Matthews (D),
Harris McDowell (D),
Brian Pettyjohn (R),
Nicole Poore (D),
Bryon Short (D),
Stephen Smyk (R),
Jeff Spiegelman (R),
Kim Williams (D),
Last Action
Signed by Governor (on 08/28/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...